NOL3 and glioblastoma: As showed in Figure 6, we found higher GALE, RPL39L, PCDHB3, GUCA1A, MICALL2, SLC35G5, MGMT, TSPAN4, NOL3 and NLRP12 expression are correlated with poor overall survival in GBM patients (Figure 6(B,G–O)).